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Globoid cell leukodystrophy ( krabbe disease) is a rare autosomal recessive 
lysosomal storage disorder caused by deficiency of galactoceramide β-Galactosidase 
enzyme and characterized by severe myeline loss and presence of globoid bodies 
in the white matter. This enzyme is responsible for the hydrolysis of galactolipids 
formed during white matter myelination. The pathologic changes in the peripheral 
and central nervous system ( globoid cell formation and decreased myelin) appeare 
to result from the toxic nature of accumulated psychosin ( galactosphingosine) and 
galactocerebroside (galactosylceramide) that can not be degraded. Nonmetabolized 
galactocerebroside stimulates the formation of the globoid cells that reflect the 
destruction of oligodendroglial cells. These cells are responsible for the elaboration 
of the myeline. Therefore, this loss leads to myelin breakdown and produce 
additional galactocerebroside and cause a vicious circle of myeline destruction.
The galactosylceramidase gene (GALC), is located on chromosome 14q 31. More 
than 70 GALC mutations, including numerous small deletions and insertions, has 
been identified in patients with all clinical types of Krabbe disease. Some mutations 
result in the infantile type if found homozygous or with another severe mutation, 
and one mutation predicts a less severe phenotype. Disease incidence in the general 
population is estimated at 1 in 201000.
Most patients with Krabbe disease(KD) present during the first 6 months of life 
(early infantile form) and only 10 percent present later (juvenile or adult onset). A 
peripheral motor sensory neuropathy occurs in all patients but the CNS symptoms 
are dominated in the infantile form. Infants with KD present with irritability, rapidly 
progressive rigidity and tonic spasms, axial hypotonia, absent reflexes, optic atrophy 
and blindness, microcephaly, seizures and startle myoclonus.Tonic extensor spasms 
occure with light, sound, or touch stimulations. Unexplained low grade fever is 
present. During 2-4 months, infants remain in a permanent opistotonus position and 
regress rapidly to decerebrate condition  and most die before 2 years old. In juvenile 
or adult form of disease, patients show the  signs of progressive walking problems, 
spastic paraparesis, cerebellar ataxia and visual failure.
In children with infantile onset KD, brain MRI shows symmetric signal abnormalities 
in the periventricular region of the posterior cerebral hemispheres and in dentate 
nucleus and cerebellar white matter. In those with juvenile or adult onset disease, 
atrophy and increased T2 signal in  white matter is present, but the dentate and 
cerebellum are generally spared. Brain magnetic resonance spectroscopy (MRS) 
shows elevation of myo-inositol and cholin- containing coumpounds in affected 
white matter.  Spinal involvement  may be evident on MRI  as abnormal contrast 
enhancement of the lumbosacral nerve roots. Abnormalities of brainstem auditory 
and visual evoked potentials are present. Motor nerve conduction velocity of 
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peripheral nerves is usually prolonged and the protein 
content  of CSF is elevated. Deficient activity of 
galactoceramide β-Galactosidase in leukocytes or 
cultured fibroblasrs confirm the diagnosis. Molecular 
genetic test is available for genetic  counseling.
There is no specific treatment for symptomatic patients 
with infantile form of KD. Supporting care is only option 
to manage irritability and spasticity. Hematopoetic  stem 
cell transplantation from unrelated donor slows the 
course of disease  in infantile form of KD diagnosed 
before the symptoms start. Newborn screening has 
been recommended for early detection and intervention 
by bone marrow transplantation to improve outcome. 
However the utility of screening is limited because 
neither enzyme activity nor knowledge of the genetic 
mutation can reliably predict phenotype. Prenatal 
diagnosis is prepared by measuring GALC activity in a 
chorionic villi sample or cultured amniocytes.
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